Rensselaer, NY – Neural Stem Cell Institute Scientists Advance Dementia Research Using 3D Brain Organoid Technology Patients with dementia suffer from tau protein aggregation and brain degeneration especially in the cerebral cortex, the major brain region responsible for decision-making, …
NSCI IND Allowance for AMD Clinical Trial
NSCI is pleased to announce our successful IND application to the FDA that will enable clinical testing of a novel stem cell therapy for patients with age-related macular degeneration (AMD). In AMD, the retinal pigment epithelial cells (RPE) at the back of the eye degenerate, causing loss of …